Download video

No views

26 minutes ago

Cell Video Part 2(HL)
10:31
Cell Video Part 2(HL)
by w2bob
GenScript's Response to the SARS-CoV-2 Pandemic: Innovations in Diagnostic Solutions with Live Q\&A
44:13
GenScript's Response to the SARS-CoV-2 Pandemic: Innovations in Diagnostic Solutions with Live Q\&A
by Labroots
The emergence of new mutations in SARS-CoV-2 and their implications
1:16:36
The emergence of new mutations in SARS-CoV-2 and their implications
by Wehealth
What’s New in Chronic Lymphocytic Leukemia (CLL)?
34:35
What’s New in Chronic Lymphocytic Leukemia (CLL)?
by Blood Cancer United
Acalabrutinib vs. Ibrutinib for Treatment of Chronic Lymphocytic Leukemia (CLL) - Dr. Lindsey Roeker
12:09
Acalabrutinib vs. Ibrutinib for Treatment of Chronic Lymphocytic Leukemia (CLL) - Dr. Lindsey Roeker
by CLL Society
Emerging role of neuroinflammation in C9orf72-ALS
42:52
Emerging role of neuroinflammation in C9orf72-ALS
by Labroots
Q2
7:01
Q2
by HoungJunHongBiology
90 Seconds of What's Next: 02.02.22
1:44
90 Seconds of What's Next: 02.02.22
by Real Chemistry
Science in Action: The Significance of OAT2 and OCT2 in Creatinine Clearance
1:06
Science in Action: The Significance of OAT2 and OCT2 in Creatinine Clearance
by Newcells Biotech
Phase 2 NOBLE Study
3:27
Phase 2 NOBLE Study
by CheckRare
Recent advances in precision oncology and future implications
4:12
Recent advances in precision oncology and future implications
by COR2ED The Heart of Medical Education
Phase II study of acalabrutinib, venetoclax, and obinutuzumab in CLL enriched for high-risk disease
2:12
Phase II study of acalabrutinib, venetoclax, and obinutuzumab in CLL enriched for high-risk disease
by VJHemOnc – Video Journal of Hematology \& HemOnc